About
Kumar Gondi, PhD, is a biopharma R&D executive and scientific advisor focused on nonclinical development, drug metabolism and pharmacokinetics, toxicology, and translational drug discovery. General Proximity says he most recently served as Senior Vice President of Nonclinical R&D at Bristol Myers Squibb, after earlier leadership roles at Celgene, Abbott, and Amgen. He is also a published scientist and co-inventor on drug-development programs including Kaletra, with recent work connected to cereblon biology and targeted protein degradation.
Areas of interest
biotechdrug discoverydrug metabolismpharmacokineticstoxicologynonclinical developmentmedicinal chemistrytargeted protein degradationcereblon biologysmall moleculesbiotherapeuticscell therapies